In per‐protocol analysis, serum MFAP4 had excellent diagnostic accuracy with an AUROC of 0.88 (95% CI 0.81‐0.94) for advanced fibrosis (≥F3) and AUROC of 0.91 (95% CI 0.83‐0.98) for cirrhosis (F4) in the training cohort; similar results were seen for the validation cohort (Table 2). The gene discussed is MFAP4; the disease is Cirrhosis.